New Delhi: Bharat Biotech on Thursday (April 29) slashed the rates of its COVID-19 vaccine ‘Covaxin’ to Rs 400 per dose for the state governments from the sooner Rs 600 per dose.
“Recognising the enormous challenges in the public healthcare system, we have made Covaxin available to state governments at a price of 400/ dose”, Bharat Biotech was quoted as saying by PTI.
Covaxin to be obtainable to State governments at a value of Rs 400 per dose: Bharat Biotech pic.twitter.com/gPPFN7mJQo
— ANI (@ANI) April 29, 2021
Earlier, Covaxin was priced at Rs 600 per dose for states, whereas Rs 1200 per dose was introduced for personal hospitals. The vaccine maker confronted backlash for its pricing coverage because it offered Covaxin to the central authorities at Rs 150 per dose.
The announcement by Bharat Biotech comes a day after the Serum Institute of India (SII) introduced to promote Covishield vaccines to states at Rs 300, lowering the rates by Rs 100.
In a assertion launched on April 24, the Hyderabad-based vaccine producer had mentioned, “Following the Govt of India directives, we announce the costs of COVAXIN vaccines – ₹600 per dose for state hospitals and ₹1,200 per dose for personal hospitals.” Export costs for the India-made Covaxin had been capped between $15-20.
(April 28). All adults are eligible to obtain the COVID-19 vaccine jab and may register themselves on the CoWIN portal or the Aarogya Setu app.
